Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study.
Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.
Comparison of Ocular Findings in Patients with H1N1 Influenza Infection versus Patients Receiving Influenza Vaccine during a Pandemic.
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.
An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.
Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targets.
Clinical and epidemiological profiles of non-traumatic myelopathies.
Good cardiac safety in patients with relapsing remitting multiple sclerosis upon first fingolimod dose.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves' disease: A case report.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Similar Effects Seen for Fingolimod, Placebo in Primary Progressive Multiple Sclerosis
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
A novel internet-based method of capturing outcomes in multiple sclerosis.
A white matter lesion-filling approach to improve brain tissue volume measurements.
[Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Microglial Physiology and Pathophysiology: Insights from Genome-wide Transcriptional Profiling.
Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue.
Pages
« first
‹ previous
…
679
680
681
682
683
684
685
686
687
…
next ›
last »